We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Transoesophageal Echocardiography in Liver Transplantation

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00547924
First Posted: October 23, 2007
Last Update Posted: April 10, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Zurich
  Purpose

Severe hypotension during reperfusion in liver transplantation is a frequent adverse event. Rare data exist so far about pathophysiology of this phenomenon. The exact role of left ventricular function, which might be impaired causing hypotension, has not been elucidated during the period of reperfusion.

Goal of this study is to:

  • perform transesophageal echocardiography in order to assess systolic and diastolic left ventricular function during reperfusion
  • determine inflammatory mediators in the plasma which could cause left ventricular dysfunction

Condition Intervention
End Stage Liver Disease Behavioral: Transoesophageal echocardiography

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Transoesophageal Echocardiography in Liver Transplantation: Left Ventricular Function During Reperfusion

Resource links provided by NLM:


Further study details as provided by University of Zurich:

Estimated Enrollment: 17
Study Start Date: April 2006
Study Completion Date: January 2010
Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Transoesophageal echocardiography
    Transoesophageal echocardiography in liver transplantation: left ventricular function during reperfusion
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients on waiting list for liver transplantation
Criteria

Inclusion criteria:

  • Patients on waiting list for liver transplantation.
  • Age: 18-75 years.

Exclusion criteria:

  • Strictures, tumours and diverticula of the oesophagus.
  • History of oesophageal varices with recent bleeding.
  • Oesophageal varices and prothrombin time less than 20% or platetlets les than 30000/ml.
  • Instable cervical spine.
  • Involvement in other studies.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00547924


Locations
Switzerland
University Hospital Zurich, Institute for Anesthesiology
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: Marco Zalunardo, MD UniversitaetsSpital Zuerich
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT00547924     History of Changes
Other Study ID Numbers: StV 11-2006
First Submitted: October 22, 2007
First Posted: October 23, 2007
Last Update Posted: April 10, 2014
Last Verified: April 2014

Additional relevant MeSH terms:
Liver Diseases
End Stage Liver Disease
Digestive System Diseases
Liver Failure
Hepatic Insufficiency


To Top